concept

PAP

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about PAP: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

38Connections

0Hypotheses

30Analyses

32Outgoing

6Incoming

No summary available yet. View on Wiki →

💡 Concept Info

Name	PAP
Summary	Page for enzymes of physiological amyloidogenesis and their role in pathological amyloid toxicity in neurodegenerative diseases
Key Genes/Proteins	SNCA, GENES, AND, HUMAN GENES, P75NTR, NEURODEGENERATIVE DISEASES
Related Diseases	ALS, Als, Cancer

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

Pathway Diagram

graph TD
    PAP["PAP"]
    PAP -->|"activates"| ALS["ALS"]
    PAP -->|"expressed in"| Als["Als"]
    PAP -->|"activates"| Cancer["Cancer"]
    PAP -->|"activates"| GENES["GENES"]
    PAP -->|"activates"| AND["AND"]
    PAP -->|"activates"| HUMAN_GENES["HUMAN GENES"]
    PAP -->|"causes"| SNCA["SNCA"]
    PER["PER"] -->|"activates"| PAP
    SNCA -->|"causes"| PAP
    P75NTR["P75NTR"] -->|"expressed in"| PAP

Outgoing (32)

Target	Relation	Type	Str
SNCA	co-deleted/mutated	gene	0.90
ALS	activates	disease	0.65
Als	expressed_in	disease	0.65
Cancer	activates	disease	0.65
ALS	expressed_in	disease	0.65
GENES	activates	gene	0.60
AND	activates	gene	0.60
HUMAN GENES	activates	gene	0.60
Neuron	associated_with	cell_type	0.60
GENES	associated_with	gene	0.60
SNCA	causes	gene	0.60
P75NTR	expressed_in	gene	0.60
AND	causes	gene	0.60
NEURODEGENERATIVE DISEASES	causes	gene	0.60
CANCER	activates	gene	0.60
Α-Synuclein	associated_with	protein	0.60
App	causes	protein	0.60
Cholesterol	causes	pathway	0.60
Neuron	therapeutic_target	cell_type	0.60
Macrophage	causes	cell_type	0.60
Monocyte	therapeutic_target	cell_type	0.60
oxidative stress response	participates_in	pathway	0.60
neurodegeneration	causes	disease	0.60
SNCA	associated_with	gene	0.60
cerebellum	expressed_in	brain_region	0.60
cancer	associated_with	disease	0.60
astrocytes	expressed_in	cell_type	0.60
macrophages	expressed_in	cell_type	0.60
NF-kB signaling	participates_in	pathway	0.60
Cortex	expressed_in	brain_region	0.55
Cerebellum	expressed_in	brain_region	0.55
Neuron	expressed_in	cell_type	0.55

Incoming (6)

Source	Relation	Type	Str
SNCA	associated_with	gene	0.60
PER	activates	gene	0.60
SNCA	causes	gene	0.60
P75NTR	expressed_in	gene	0.60
IKBKG	activates	gene	0.60
NEMO	activates	gene	0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (30)

Scientific analyses that reference this entity

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

neuroinflammation | 2026-04-15 | 1 hypotheses Top: 0.650

Should microtubule-stabilizing drugs be reconsidered as therapeutic targets for

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.609

How does engineered C. butyricum cross the blood-brain barrier to directly bind

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.675

What are the physiological functions of BACE1 beyond APP processing that could c

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.527

Why does iron chelation therapy worsen outcomes in H63D HFE variant carriers des

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.586

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

PAP

Understanding Entity Pages

Wiki Pages (21)

Enzymes of Physiological Amyloidogenesis in Neurodegeneration

Clinical Management Guide for CBS/PSP

Astrocytes

Sleep and Glymphatic Tau Clearance in Tauopathies

Sleep Architecture Changes in CBS and PSP

potassium-channel-openers-parkinsons

Tau Kinase Signaling Cascade in Alzheimer's Disease

Autoimmune Encephalitis

Sulfatide Metabolism in Neurodegeneration

Tripartite Synapse

PABPN1

CSF2RA — Colony Stimulating Factor 2 Receptor Alpha Chain

GAL3ST1 Protein

PLPPR1 Gene

GM-CSF Receptor Alpha Chain

REG3A Protein

Sleep-Disordered Breathing in Progressive Supranuclear Palsy

Astroglia (Astrocytes)

GAL3ST1 Gene

PABPN1 Protein

REG3A — Regenerating Family Member 3 Alpha

Pathway Diagram

Outgoing (32)

Incoming (6)

Targeting Hypotheses (0)

Mentioning Analyses (30)

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

Should microtubule-stabilizing drugs be reconsidered as therapeutic targets for

How does engineered C. butyricum cross the blood-brain barrier to directly bind

What are the physiological functions of BACE1 beyond APP processing that could c

Why does iron chelation therapy worsen outcomes in H63D HFE variant carriers des

What upstream mechanisms trigger p53 activation specifically in response to poly

How does SYNGAP1, a 'synaptic' protein, function in pre-synaptic radial glia cel

What molecular mechanisms link elevated sphingomyelin synthase activity to incre

What molecular mechanisms explain how apoE promotes cerebral amyloid angiopathy

Why does PRKN-mediated mitophagy, typically protective, cause harmful mitochondr

What molecular mechanisms cause iPLA2β deficiency to specifically damage mitocho

What molecular mechanisms enable Gal3 to enhance tau fibrillation upon binding t

What molecular mechanisms drive the transition from acute to persistent neuroinf

Why does autophagy inhibition improve neuronal survival when autophagy is typica

What molecular mechanisms mediate HDAC9's effects on Aβ deposition and synaptic

What molecular mechanisms mediate HDAC9's effects on Aβ deposition and synaptic

Why is TYROBP deficiency neuroprotective when TYROBP is an adapter for multiple

Why does Metformin fail to delay CJD progression despite improving anti-aging ha

Does clusterin exacerbate or protect against neuronal death in neurodegeneration

What specific molecular mechanisms link APOE4 to cholesterol dysregulation in ol

How does pericyte senescence mechanistically promote glioma cell growth and inva

What are the molecular mechanisms by which GLP-1RAs provide neuroprotective effe

What are the specific circulating factors in exercise-conditioned plasma that me

What genetic risk factors predispose individuals to developing CTE following rep

Why do p300/CBP inhibitors reduce both AD incidence and clinically diagnosed TBI

How does FUS loss-of-function in TAZ regulation contribute to ALS/FTD pathogenes

How does APOE4's beneficial immune function reconcile with its established role

How do ALS-associated OPTN mutations mechanistically disrupt Rab8a binding and c

What molecular mechanisms determine whether reactive astrocytes adopt neurotoxic

What molecular mechanisms enable functional recovery and muscle re-innervation a

Related Papers (0)